These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20734456)

  • 21. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.
    Shorr AF; Tabak YP; Killian AD; Gupta V; Liu LZ; Kollef MH
    Crit Care Med; 2006 Oct; 34(10):2588-95. PubMed ID: 16915117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections.
    Laohavaleeson S; Barriere SL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2008 Dec; 28(12):1471-82. PubMed ID: 19025428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?
    Eagye KJ; Kim A; Laohavaleeson S; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2009 Aug; 10(4):323-31. PubMed ID: 19622027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections.
    Zilberberg MD; Chaudhari P; Nathanson BH; Campbell RS; Emons MF; Fiske S; Hays HD; Shorr AF
    BMC Infect Dis; 2012 Jul; 12():154. PubMed ID: 22784260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.
    Wargo KA; McCreary EK; English TM
    Clin Infect Dis; 2015 Oct; 61(7):1148-54. PubMed ID: 26082508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications.
    Shorr AF; Micek ST; Kollef MH
    Crit Care Med; 2008 Aug; 36(8):2335-40. PubMed ID: 18596624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
    Snydman DR
    J Hosp Med; 2012; 7 Suppl 1():S2-S12. PubMed ID: 23737334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
    Snydman DR
    J Hosp Med; 2012; 7 Suppl 1():S2-12. PubMed ID: 23677631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections.
    Kang CI; Sung YK; Lee KH; Lee KT; Lee JK
    Scand J Infect Dis; 2013 Mar; 45(3):227-34. PubMed ID: 23113605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus.
    Chuck EA; Frazee BW; Lambert L; McCabe R
    J Emerg Med; 2010 Jun; 38(5):567-71. PubMed ID: 18514468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of methicillin-resistant Staphylococcus aureus infection and empirical antibiotic therapy for MRSA infection: multicenter investigation.
    Deng LJ; Wu XD; Kang Y; Xu Y; Zhou JX; Wang DF; Chen DC
    Chin Med J (Engl); 2013; 126(19):3745-9. PubMed ID: 24112175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
    Reed SD; Friedman JY; Engemann JJ; Griffiths RI; Anstrom KJ; Kaye KS; Stryjewski ME; Szczech LA; Reller LB; Corey GR; Schulman KA; Fowler VG
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):175-83. PubMed ID: 15756889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
    Schreiber MP; Chan CM; Shorr AF
    J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
    Deresinski SC
    Diagn Microbiol Infect Dis; 2008 May; 61(1):103-9. PubMed ID: 18384998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience.
    Zilberberg MD; Shorr AF; Micek ST; Mody SH; Kollef MH
    Chest; 2008 Nov; 134(5):963-968. PubMed ID: 18641103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.